|
1
|
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
|
Lancet Oncol
|
2008
|
5.93
|
|
2
|
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients.
|
J Clin Invest
|
2008
|
2.73
|
|
3
|
Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer.
|
Transpl Int
|
2013
|
2.53
|
|
4
|
Body surface area and body weight predict total liver volume in Western adults.
|
Liver Transpl
|
2002
|
2.21
|
|
5
|
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).
|
J Hepatol
|
2012
|
2.15
|
|
6
|
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation.
|
Liver Transpl
|
2013
|
2.09
|
|
7
|
Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry.
|
Liver Transpl
|
2003
|
2.01
|
|
8
|
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
|
Ann Surg
|
2013
|
1.98
|
|
9
|
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome.
|
Lancet
|
2006
|
1.97
|
|
10
|
Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.
|
Hepatology
|
2013
|
1.93
|
|
11
|
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.
|
Ann Surg
|
2004
|
1.79
|
|
12
|
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
|
Transplantation
|
2016
|
1.59
|
|
13
|
Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
|
Liver Transpl
|
2005
|
1.52
|
|
14
|
Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound.
|
Eur J Gastroenterol Hepatol
|
2007
|
1.42
|
|
15
|
Liver transplantation for unresectable hepatocellular carcinoma in normal livers.
|
J Hepatol
|
2012
|
1.42
|
|
16
|
Liver segmentation in living liver transplant donors: comparison of semiautomatic and manual methods.
|
Radiology
|
2004
|
1.39
|
|
17
|
The place of liver transplantation in Caroli's disease and syndrome.
|
Transpl Int
|
2006
|
1.23
|
|
18
|
Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.
|
J Hepatol
|
2012
|
1.14
|
|
19
|
Waiting time and transplantation for hepatocellular cancer: a balance between Tempus Fugit and Carpe Diem.
|
Hepatology
|
2015
|
1.08
|
|
20
|
Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?
|
Nephrol Dial Transplant
|
2010
|
1.08
|
|
21
|
Inflammation-based scores and hepatocellular carcinoma: "Faithful friends are hard to find".
|
Liver Transpl
|
2014
|
1.07
|
|
22
|
α-Fetoprotein and hepatocellular cancer recurrence: a paradigm of the chaos theory.
|
Liver Transpl
|
2014
|
1.04
|
|
23
|
Congenital intrahepatic bile duct dilatation is a potentially curable disease: long-term results of a multi-institutional study.
|
Ann Surg
|
2007
|
1.03
|
|
24
|
Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
|
J Am Coll Surg
|
2007
|
1.01
|
|
25
|
Liver transplantation for hepatocellular cancer: UCL experience in 137 adult cirrhotic patients. Alpha-foetoprotein level and locoregional treatment as refined selection criteria.
|
Transpl Int
|
2012
|
0.95
|
|
26
|
1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation.
|
Pharmacogenet Genomics
|
2007
|
0.92
|
|
27
|
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
|
Liver Transpl
|
2011
|
0.91
|
|
28
|
Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
|
Transpl Int
|
2006
|
0.90
|
|
29
|
Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review.
|
Transpl Int
|
2010
|
0.89
|
|
30
|
Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience.
|
Transplantation
|
2013
|
0.87
|
|
31
|
Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study.
|
Transpl Int
|
2011
|
0.87
|
|
32
|
Successful treatment of recurrent cholangitis after adult liver transplantation with a Tsuchida antireflux valve.
|
Transplantation
|
2004
|
0.85
|
|
33
|
Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007.
|
Transpl Int
|
2009
|
0.83
|
|
34
|
A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation: Time-Radiological-response-Alpha-fetoprotein-INflammation (TRAIN) Score.
|
Ann Surg
|
2016
|
0.83
|
|
35
|
Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
|
Transplantation
|
2008
|
0.83
|
|
36
|
Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system.
|
Liver Transpl
|
2008
|
0.82
|
|
37
|
Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients.
|
Eur J Gastroenterol Hepatol
|
2010
|
0.81
|
|
38
|
Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells.
|
Ther Drug Monit
|
2009
|
0.81
|
|
39
|
Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study.
|
Dig Liver Dis
|
2012
|
0.81
|
|
40
|
Stepwise minimization of the immunosuppressive therapy in pediatric liver transplantation. A conceptual approach towards operational tolerance.
|
Acta Gastroenterol Belg
|
2005
|
0.81
|
|
41
|
Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up.
|
Transpl Int
|
2005
|
0.81
|
|
42
|
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report.
|
Liver Int
|
2007
|
0.81
|
|
43
|
Surgical management of congenital intrahepatic bile duct dilatation, Caroli's disease and syndrome: long-term results of the French Association of Surgery Multicenter Study.
|
Ann Surg
|
2013
|
0.80
|
|
44
|
Living Donor Liver Transplantation in Children: Surgical and Immunological Results in 250 Recipients at Université Catholique de Louvain.
|
Ann Surg
|
2015
|
0.80
|
|
45
|
How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?
|
World J Gastroenterol
|
2012
|
0.80
|
|
46
|
Re-use of a liver allograft; an exceptional opportunity to enlarge the organ donor pool.
|
Transpl Int
|
2003
|
0.79
|
|
47
|
Long-term survival after isolated liver transplantation for intrahepatic biliary papillomatosis.
|
Transpl Int
|
2006
|
0.79
|
|
48
|
How much immunosuppression is needed after liver transplantation?
|
Clin Transplant
|
2013
|
0.79
|
|
49
|
Long-term medical complications and quality of life in adult recipients surviving 10 years or more after liver transplantation.
|
Acta Gastroenterol Belg
|
2005
|
0.78
|
|
50
|
Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature.
|
Transpl Int
|
2013
|
0.78
|
|
51
|
Biliary cast syndrome after liver transplantation.
|
ANZ J Surg
|
2012
|
0.78
|
|
52
|
Hematochezia and congenital extrahepatic portocaval shunt with absent portal vein: successful treatment by liver transplantation.
|
Transplantation
|
2004
|
0.78
|
|
53
|
Liver transplantation in children with fulminant hepatic failure: The UCL experience.
|
Pediatr Transplant
|
2008
|
0.77
|
|
54
|
Extension of the adult hepatic allograft pool using split liver transplantation.
|
Acta Gastroenterol Belg
|
2005
|
0.77
|
|
55
|
Reply to 'neutrophil and platelet-to-lymphocyte ratio: new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer?'.
|
Transpl Int
|
2014
|
0.77
|
|
56
|
Living-related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma.
|
Transplantation
|
2002
|
0.77
|
|
57
|
Pediatric liver transplantation using left hepatic segments from living related donors: surgical experience in 100 recipients at Saint-Luc University Clinics.
|
Pediatr Transplant
|
2006
|
0.77
|
|
58
|
Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.
|
Ther Drug Monit
|
2007
|
0.77
|
|
59
|
The International Liver Transplant Society Guideline on Living Liver Donation.
|
Transplantation
|
2016
|
0.77
|
|
60
|
Internalizing motivation to self-care: a multifaceted challenge for young liver transplant recipients.
|
Qual Health Res
|
2014
|
0.76
|
|
61
|
Vaginal bleeding complicating portal hypertension: a particular entity - report of two cases and review of the literature.
|
Transpl Int
|
2005
|
0.76
|
|
62
|
Reply to: Cancer inflammation and inflammatory biomarkers: can neutrophil, lymphocyte, and platelet counts represent the complexity of the immune system?
|
Transpl Int
|
2014
|
0.75
|
|
63
|
Defining Benchmarks for Major Liver Surgery: A multicenter Analysis of 5202 Living Liver Donors.
|
Ann Surg
|
2016
|
0.75
|
|
64
|
Energy drinks: another red flag for the liver allograft.
|
Liver Transpl
|
2011
|
0.75
|
|
65
|
The true merits of liver allocation according to MELD scores: survival after transplantation tells only one side of the story.
|
Transpl Int
|
2011
|
0.75
|
|
66
|
Leiomyoma mimicking an incarcerated inguinal hernia: A rare complication of laparoscopic hysterectomy.
|
J Minim Access Surg
|
2011
|
0.75
|
|
67
|
Bioengineering a Human Face Graft: The Matrix of Identity.
|
Ann Surg
|
2017
|
0.75
|
|
68
|
The one hundred most frequently cited articles in the field of clinical liver transplantation.
|
Transpl Int
|
2012
|
0.75
|
|
69
|
Transplant International. Editorial.
|
Transpl Int
|
2009
|
0.75
|
|
70
|
Vacuum-assisted closure for abdominal wound dehiscence with prosthesis exposure in hernia surgery.
|
Plast Reconstr Surg
|
2003
|
0.75
|
|
71
|
Successful liver transplantation in an adult residual atrial septal defect and left-to-right shunt.
|
Chir Ital
|
2008
|
0.75
|
|
72
|
Risk factors associated with outcome in liver retransplantation: multicentric study.
|
Hepatogastroenterology
|
2015
|
0.75
|
|
73
|
Which Is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?
|
Ann Surg
|
2017
|
0.75
|
|
74
|
Temporary transjugular intrahepatic portosystemic shunt to overcome small-for-size syndrome after right lobe adult split liver transplantation.
|
Transpl Int
|
2006
|
0.75
|
|
75
|
The modernized treatment of hepatocellular cancer: time to think twice!
|
Updates Surg
|
2011
|
0.75
|
|
76
|
Professor Gilles Mentha (1952-2014).
|
Transpl Int
|
2014
|
0.75
|
|
77
|
Post-splenectomy pancreatic pseudocyst and extensive thrombosis of the portal venous system in a liver transplant recipient.
|
J Hepatol
|
2002
|
0.75
|
|
78
|
The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline.
|
Transplantation
|
2017
|
0.75
|
|
79
|
Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results.
|
Ann Surg
|
2017
|
0.75
|
|
80
|
Comparison of different methods to quantify future liver remnants after preoperative portal vein embolization to predict postoperative liver failure.
|
Hepatogastroenterology
|
2011
|
0.75
|
|
81
|
Successful treatment of haemothorax following percutaneous liver biopsy using interventional radiology: importance of arterial anatomical variations.
|
Transpl Int
|
2008
|
0.75
|
|
82
|
Liver transplantation for malignancies. How did we get there?
|
Transpl Int
|
2010
|
0.75
|
|
83
|
Limited lamivudine and long-term hepatitis B immunoglobulin immunoprophylaxis for prevention of hepatitis B recurrence after liver transplantation.
|
Transplantation
|
2002
|
0.75
|
|
84
|
HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY.
|
Transplantation
|
2016
|
0.75
|
|
85
|
The International Liver Transplant Society (ILTS) Living Donor Liver Transplant Recipient Guideline.
|
Transplantation
|
2016
|
0.75
|
|
86
|
Complex hepatic outflow reconstruction in domino liver transplantation.
|
Hepatobiliary Pancreat Dis Int
|
2014
|
0.75
|